Final answer:
The HPV vaccine protects against infection by stimulating the immune response to high-risk HPV types, especially types 16 and 18 which are linked with a majority of cervical cancer cases. It is administered before sexual activity begins for maximum efficacy and is recommended for both sexes to reduce cervical and other HPV-related cancers.
Step-by-step explanation:
The HPV vaccine is believed to protect against infection by introducing components such as virus-like particles, dead or inactivated viruses, genetically engineered pieces of a pathogen, or purified viral proteins that stimulate the body's immune response without causing the disease. These components prepare the immune system to recognize and combat the virus if the person is later exposed to it. HPV strains, particularly types 16 and 18, are linked to a significant proportion of cervical cancer cases; the vaccine targets these high-risk strains. By getting vaccinated, individuals are less likely to develop oncogenic HPV infections, leading to a decrease in the prevalence of cervical cancer and genital warts caused by these strains. The HPV vaccine is recommended for both boys and girls and should be given before the onset of sexual activity to achieve maximum efficacy.
Vaccination is the most effective method for preventing HPV infection, and regular Pap testing along with HPV vaccination forms a comprehensive approach to reducing the risk of cervical cancer. The introduction of the HPV vaccine has been associated with a significant reduction in the rates of infection by the targeted strains. It is recommended for recipients to receive the vaccine at the recommended ages to ensure the best protection against these high-risk HPV types.